reports
Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Ann...
Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce Receipt of Shareholder Approvals for Merger of Equals SHIPPENSBURG, Pa. and YORK, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (“Orrstown”) (NASDAQ: ORRF), the parent company of Orrstown Bank, and Codorus Valley Bancorp, Inc. (“Codorus Valley”) (NASDAQ: CVLY), the parent company of PeoplesBank, A Codorus Valley Company, today announced that they each received shareholder approval for the previously announced merger of equals. At a special meeting of shareholders held on May 30, 2024, Cod...
Euronet Expands Malaysian Market Presence with the Acquisition of MEPS...
Euronet Expands Malaysian Market Presence with the Acquisition of MEPS ATM Terminals from PayNet Euronet will acquire about 800 ATMs, making it the largest non-bank ATM terminal operator in Malaysia LEAWOOD, Kan., May 30, 2024 (GLOBE NEWSWIRE) -- Euronet (NASDAQ: EFFT), a leading global financial technology solutions and payments provider, announced today the completion of the acquisition of the Malaysian Electronic Payment System (MEPS) ATM terminals of Payments Network Malaysia Sdn Bhd (PayNet), the national payments network and central financial infrastructure for Malaysia. This ac...
Super League CEO, Ann Hand, to Participate in Maxim Group Virtual Fire...
Super League CEO, Ann Hand, to Participate in Maxim Group Virtual Fireside Chat on the Marketing Channel of the Future, Leading Global Brands into 3D Immersive Platforms SANTA MONICA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leading creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, today announced the Company will participate in a virtual fireside chat hosted by the Maxim Group’s Jack Vander Aarde on Wednesday, June 5, 2024, at 2:30pm ET. During the fireside chat, SLE’s Chief Exec...
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Cardiff Oncology to Present at the Jefferies Healthcare Conference SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in a company presentation and 1x1 investor meetings at the Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York from June 5-6, 2024. Details of the presentations can be found below. Presenters: Mark Erlander, CEODate: June 5, 20...
Savara to Present at the Jefferies Global Healthcare Conference
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:00am PT/10:00am ET. A live webcast of the fireside chat will be available on Savara’s website at and will be archived for 90 days. About Savara Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophag...
- Jonathan Moreland
SUN SUNOCO LP
HEAR TURTLE BEACH CORP
CLFD CLEARFIELD INC.
ADC AGREE REALTY CORPORATION
BCBP BCB BANCORP INC.
MCFT MASTERCRAFT BOAT HOLDINGS
GL GLOBE LIFE INC.
RZLT REZOLUTE
HQI INC.
COOK HIREQUEST INC.
TMCI TRAEGER
SOFI INC.
PFHC TREACE MED CONCEPTS INC
OABI SOFI TECHNOLOGIES INC
BYON PROFRAC HLDG CORP
OMNIAB INC
BEYON 3D LTD
Longeveron® to Attend BIO International Convention 2024
Longeveron® to Attend BIO International Convention 2024 MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company will participate in the taking place June 3-6, 2024 at the San Diego Convention Center. At the conference, members of the Longeveron management team will host meetings with global pharmaceutical company executives to explore potential partnership and strategic opportunities for the Company’s , wh...
Agree Realty Corp: 2 directors
Two Directors at Agree Realty Corp bought 21,000 shares at between 58.990USD and 59.320USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Hybridan Small Cap Feast - 28 May 24
28th May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: Accrol Group Holdings (ACRL.L) has left AIM. China Nonferrous Gold Limited (CNG.L) has left AIM. What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: 7th May: Time To ACT plc, an engineering business focused o...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
WST WEST PHARMACEUTICAL SERVICES INC.
WBA WALGREENS BOOTS ALLIANCE INC
TWI TITAN INTERNATIONAL INC.
SSYS STRATASYS LTD.
PII POLARIS INC.
NDSN NORDSON CORPORATION
MYE MYERS INDUSTRIES INC.
MIDD MIDDLEBY CORPORATION
LEA LEAR CORPORATION
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
DOX AMDOCS LIMITED
CLX CLOROX COMPANY
AGCO AGCO CORPORATION
MG/CN MAGNA INTERNATIONAL INC.
CAH CARDINAL HEALTH INC.
IONS IONIS PHARMACEUTICALS INC.
LEG LEGGETT & PLATT INCORPORATED
MAT MATTEL INC.
PARR PAR PACIFIC HOLDINGS INC
SAM BOSTON BEER COMPANY INC. CLASS A
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
THO THOR INDUSTRIES INC.
THS TREEHOUSE FOODS INC.
CSCO CISCO SYSTEMS INC.
WGO WINNEBAGO INDUSTRIES INC.
BMY BRISTOL-MYERS SQUIBB CO. CEDEAR
SUZBY SUZANO SA
TXG 10X GENOMICS INC CLASS A
LI LI AUTO INC. SPONSORED ADR CLASS A
CRC CALIFORNIA RESOURCES
VRDN VIRIDIAN THERAPEUTICS INC
OI O I GLASS INC COM
OKLO OKLO INC CL A
SJM JM SMUCKER CO COM
Hybridan Small Cap Feast - 22 May 24
22nd May 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: ITF announced: 7th May: Time To ACT plc, an engineering business focused on technology for the energy transition sector, has announced its intention to seek Admission to t...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
Vital Signs - Charts of the Day: ONON, CDRO, DESP, DBD, LFUS, OUST, UI, VTS, WLFC, HOOD, JXN, FG, ACIC, CB, NMRK, AOMR, COFS, UBAB, HIMS, PNTH, RNA, CDNA, DCTH, EBS, HROW, PRIM, ACDC, LBRT, AA, CENX, SCCO, FCX, AU, CDE, GATO, HL, RGLD, LXU, PLL, PRM, RBC, In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bot...
ROLL RBC BEARINGS INCORPORATED
LXU LSB INDUSTRIES INC.
LFUS LITTELFUSE INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
WLFC WILLIS LEASE FINANCE CORP.
DESP DESPEGAR.COM CORP.
UI UBIQUITI INC.
CB CHUBB CORP
ONON ON HLDNG AG
HOOD ROBINHOOD MARKETS INC
JXN JACKSON FINANCIAL INC
PLL PIEDMONT LITHIUM INC
PRM PERIMETER SOLUTIONS SA
CDRO CODERE ONLINE LUXEMBOURG SA
FG WI F&G ANNUITIES & LIFE INC
VTS_w VITESSE ENERGY INC
OUST OUSTER INC
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis...
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego, CA. Savara’s partner, Trillium Health LLC, presented a poster on the laboratory blood test that was recently developed to aid in the diagnosis of aPAP. Below are summaries of the posters presented: Poster Board 701: “Healthcare Burden of Pulmonary Alveolar Proteinosis” presented by E. Lee, M.D., Ph.D.; sponso...
Savara Announces New Employment Inducement Grant
AUSTIN, Texas--(BUSINESS WIRE)-- (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On May 14, 2024, the Compensation Committee of Savara's Board of Directors granted the inducement awards to a new employee who recently joined the Company. The inducement awards consist of options to purchase 15,000 shares of the Company’s common stock and restricted stock units (RSUs) covering 2,500 shares of the Company’s common stock. These equity awards were granted under the Savara Inc. 2021 I...
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect...
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that Sath Shukla, President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat and be available for one-on-one meetings at the , to take place on Monday, May 20, 2024, at the NAS...
Super League Announces First Quarter 2024 Financial Results
Super League Announces First Quarter 2024 Financial Results ~ Q1 2024 Revenues Increase 27% from Q1 2023 to $4.2 Million ~ ~ Strategic Partnerships Formed with Chartis and GSTV ~ SANTA MONICA, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leading creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, has released its first quarter 2024 financial results in the form of a . A webinar hosted by Ann Hand, CEO of Super League, and Clayton Haynes, CFO of Super League, will be streamed beginning...
Agile Therapeutics Reports First Quarter 2024 Financial Results and Pr...
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2024 and provided a corporate update. “We are excited about the start of 2024, which saw a rebound in demand, factory sales and net sa...
Spero Therapeutics Announces First Quarter 2024 Operating Results and ...
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024Enrollment ongoing in PIVOT-PO, a pivotal Phase 3 clinical trial of oral tebipenem HBr in cUTIReceived FDA Fast Track designation for SPR206 for treatment of HABP/VABP due to CRABc and CRPACash balance of $82.3 million as of March 31, 2024; reiterate expected cash runway into late 2025 CAMBRIDGE, Mass., May 15, 2024 (GLOBE NEWSWI...
Longeveron Announces First Quarter 2024 Financial Results and Provides...
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update Phase 2b clinical trial evaluating Lomecel-BTM in rare pediatric disease HLHS on track for completing enrollment by end of 2024Data from Phase 2a clinical trial evaluating Lomecel-BTM in Alzheimer’s Disease selected for Featured Research Oral Presentation at 2024 Alzheimer’s Association International ConferenceCompleted two financings in April raising gross proceeds of $11.4 million to fund continued clinical developmentFocused expenditure management reduced first quarter Total Operating Expenses 8% year-...
Cardiff Oncology to Present at Upcoming Investor Conferences in May
Cardiff Oncology to Present at Upcoming Investor Conferences in May SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in May 2024. Details of the presentations can be found below. H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQLocation: The Nasdaq Headquarters, New York CityPresenter: Mark Erlander, CEOFormat: Fireside ChatDate:...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.